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Summary
Obesity is associated with the metabolic syndrome. The aims were, first, to study
the postprandial triglyceride clearance in young, healthy obese subjects and,
second, to investigate if fasting triglycerides can predict delayed postprandial
triglyceride clearance. Eighteen apparently healthy, obese subjects with no clinical
signs of metabolic disturbances participated. Controls were age- and sex-matched,
healthy, normal weight subjects. Subclinical markers of metabolic disturbances
were assessed by measuring postprandial triglycerides in serum and in
chylomicrons by oral fat tolerance test. Postprandial triglyceride clearance for 8 h
was assessed indirectly as removal of the lipid from serum during the oral fat
tolerance test. Insulin resistance was measured by the homeostasis model assess-
ment of insulin resistance (HOMA-IR). Twelve (66%) of the apparently healthy
obese individuals had insulin resistance measured by HOMA-IR. There was a
delayed clearance of serum triglycerides and chylomicron triglycerides at 6 h when
compared with the control group, while, at 8 h, the differences were only detected
for the chylomicron triglyceride clearance. Triglyceride response was significantly
greater in the obese subjects. Fasting triglycerides in upper normal level predicted
a delayed postprandial triglyceride clearance and insulin resistance. In young,
apparently healthy obese subjects early metabolic disturbances including insulin
resistance and delayed postprandial triglyceride clearance can be detected. Fasting
serum triglyceride in upper normal level predicted delayed postprandial triglyc-
eride clearance and insulin resistance.
Keywords: Chylomicrons, fasting triglycerides, insulin resistance, metabolic
healthy obese.
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What is already known about this subject
• Up to 10% of obese subjects can be considered metabolically
healthy to date.
• Postprandial triglyceridaemia is well documented in overweight and
obese subjects with fasting hypertriglyceridaemia.
• Diverging results exist for chylomicron triglycerides.
What this study adds
• As far as we know, this is the first report that shows that metabolically
apparently healthy obese subjects have a delayed postprandial
clearance of chylomicron triglycerides.
• This study also points out the possible need of a new and lower
reference level for fasting triglyceride levels in obese subjects.
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Introduction
Overweight and obesity, the sixth most important risk
factor for global death and disease burden (1), are raising
global health problems with several metabolic disturbances
and comorbidities, such as type 2 diabetes and cardiovas-
cular disease. Environmental challenges such as a sedentary
lifestyle and excessive intake of processed food contribute
to the increased prevalence of obesity (2,3), with a
substantial part of life in the postprandial state.
Hypertriglyceridaemia is the typical lipid disturbance in
overweight and obesity (4) and contributes to atheroscle-
rosis. A milestone in the understanding of the atheroscle-
rotic process was the proposal of Zilversmith in 1979 (5) of
a reduced and prolonged clearance of postprandial accu-
mulation of triglyceride-rich lipoproteins (TRLs) as one of
the main pathophysiological events in the atherosclerotic
process. This was later supported by studies showing that
chylomicron (CM) remnant particles penetrate efficiently
and are retained selectively in early atherosclerotic lesions
of the vessel wall (6,7), and contribute to coronary athero-
sclerotic disease by delayed elimination of postprandial
TRL (8,9). The enzyme lipoprotein lipase (LPL) plays a
pivotal role in the lipoprotein metabolism by hydrolysing
TG in CM. Activation of LPL results in hydrolysing of CM
and development of TG in small CM remnants (10), hydro-
lysing TG in very low-density lipoproteins (VLDLs) assem-
bled in the liver, contributing fatty acids to the vascular
endothelium and, finally, removing them from the blood-
stream (11). LPL activity in the vascular endothelium is
regulated by insulin, and the insulin resistance (IR) typi-
cally found in overweight and obese individuals (12) may
contribute to a delayed removal of postprandial TRL and
its highly association to overweight (4) and especially to
abdominal obesity (13–16).
Our knowledge of lipid disturbances in young, healthy
overweight and obese subjects is poor, especially for post-
prandial triglyceride metabolism focusing on CM. Both
delayed postprandial plasma TG response, in obese men
and women (17), and serum TG (SE-TG) (18) in over-
weight men have been detected, but as far as we know no
differences have been found in the CM compartment.
Therefore, in this report postprandial TG metabolism in
serum and in CM has been studied in young, apparently




Volunteers were recruited from the Centre of Obesity,
Department of Gastroenterology and Nutrition, University
Hospital of North Norway. Posters were also used to
recruit obese individuals and healthy controls to participate
in the study. The inclusion criteria for the obese subjects
were body mass index (BMI) >30 kg m−2, age 18–40 years
old, normotensive, normoglycaemic, normolipaemic, no
history of diabetes and not pregnant. Exclusion criteria
were smoking, serious mental and somatic diseases, and
patients on anti-obesity drugs. The inclusion and exclusion
criteria for the age- and sex-matched healthy controls were
the same, except having normal weight (BMI < 25).
Participants were informed and signed a written consent.
Of the 40 obese subjects who were screened for participa-
tion, 13 did not answer after receiving more info, and nine
were excluded mainly because of high blood pressure and
high blood lipids. The remaining 18 subjects were eligible
to participate, and were defined as ‘healthy obese’. A
‘healthy obese’ individual is, in this study, defined as an
obese individual whom would be classified as apparently
healthy by standard clinical evaluation and biochemical
measurements by a general practitioner.
Height, body weight, BMI and waist circumference were
measured and blood tests were drawn. These included
fasting glucose (FG), total cholesterol, low-density lipopro-
tein (LDL) cholesterol, high-density lipoprotein (HDL)
cholesterol and TG.
Dual X-ray absorptiometry (DEXA; Lunar Prodigy
Advance, GE Healthcare, USA) was collected at baseline
for all subjects. The DEXA measured total fat percentage,
abdominal fat percentage, total fat mass (kg) and total
muscle mass (kg).
Oral glucose tolerance test (OGTT)
OGTT was conducted using an oral intake of 75 g of
glucose in solution, after a 12 h night-fast. Blood tests were
drawn from the antecubital vein before ingestion (0 min)
and at 30, 60, 90 and 120 min after intake. Glucose and
insulin were measured at all time points.
Oral fat tolerance test
On the test day, the participants did an 8 h oral fat toler-
ance test (OFTT) to indirectly measure TG clearance.
OFTT has been proven to be a good, indirect and qualita-
tive measure of triglyceride clearance (19). Three days prior
to testing, the subjects had a normal food intake, no
alcohol intake and had abstained from heavy physical
activity. The participants fasted for 12 h before the start of
the test. They were at rest and not allowed to smoke, chew
a gum or drink anything other than water during the test
day. The OFTT was conducted using a test meal prepared
from standard sour cream porridge and double cream,
together containing 70% calories of fat, of which 66% was
saturated fat, 32% was monounsaturated fat and 2%
was polyunsaturated fat (20). A freshly prepared test meal
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was served with two teaspoons of white sugar (10 g of
carbohydrates), cinnamon and one glass (100 mL) of
calorie-free lemonade. The participants were served a
weight-adjusted meal (1 g of fat per kg body weight) at
08:00 h (baseline) and the meal was consumed within a
15-min period. The participants were offered a 500-mL
calorie-free beverage and one fruit (pear or apple) at
12:00 h (4 h). Blood samples for serum and Ethylenedia-
minetetraacetic acid (EDTA) plasma for isolation of CM
were collected before the test meal (baseline) and every
second hour over the next 8 h. The TG clearances at 6 and
8 h were calculated by the following formula: Clearance
6 h = 100 × (1 − ({[TG (6 h) − TG (0 h)]/[TG (max) − TG
(0 h)]}). Triglyceride response (TGR) in CM and in SE-TG
was calculated as the mean of the two highest postprandial
values minus the baseline value of SE-TG (21).
Isolation of CMs
CM were isolated by overlayering 8 mL of EDTA plasma
with 5 mL of natrium chloride (NaCl) solution (a density of
1.006 kg L−1 NaCl solution with 0.02% sodium azide and
0.01% EDTA) in a cellulose nitrate tube (Beckman Instru-
ments Inc., CA, USA) and centrifuged in a Beckman SW40
Ti swinging bucket rotor (Beckman Coulter Inc., Brea,
California, USA) at 20 000 rpm for 1 h at 20° C (22). The
CM, with Svedberg flotation rates >400 × 10−13 s, was care-
fully removed by aspiration from the top of the tubes by
(23) dividing into three aliquots in cryovials, flushed with
nitrogen and frozen at −70° C until further analysis.
Serum lipid and apolipoprotein measurements
Serum lipids were analysed on a Hitachi 737 automatic
analyser (Boehringer Mannheim GmbH, Mannheim,
Germany) according to manufacturer’s recommendations.
Total cholesterol (our laboratory reference value was
18–29 years: 2.9–6.1 mmol L−1, 30–49 years: 3.3–
6.9 mmol L−1, ≥50 years: 3.9–7.8 mmol L−1) was measured
with an enzymatic colorimetric method (CHOD-PAP) and
HDL cholesterol (our laboratory reference value was for
women: 1.0–2.7 mmol L−1 and men: 0.8–2.1 mmol L−1)
was assayed by the same procedure after precipitation LDL
with heparin and manganese chloride as described by
Burstein et al. (24). TG concentration in serum (our labora-
tory reference value was 0.5–2.6 mmol L−1) and in CM was
determined with an enzymatic colorimetric test (GPO-
PAP). LDL cholesterol was calculated by the formula of
Friedewald et al. (25): LDL cholesterol = Total choles-
terol − HDL cholesterol − 0.47 × serum triglycerides.
Apolipoproteins A-I and B-100 (ApoB-100) were measured
immunochemically by rate nephelometry using the Array
Protein System from Beckman Instruments Inc. (Brea, CA,
USA).
Measurements for insulin sensitivity
Serum insulin was analysed directly through a commercial
enzyme-linked immunosorbent assay (ELISA) kit (DRG
insulin ELISA kit, DRG Instruments GmbH, Marburg,
Germany). IR determination by the homeostasis model
assessment of IR (HOMA-IR) and supplementary by the
whole body insulin sensitivity index (WBISI) were calcu-
lated. IR was calculated as follows: HOMA-IR = Fasting
insulin (FI) (mU L−1) × FG (mmol L−1)/22.5 (26), WBISI =
10 000/[FI (mU L−1) × FG (mg dL−1) × mean insulin
(mU L−1) × mean glucose (mg dL−1)]1/2 (27). The cut-off
value of 95% confidence interval (CI) of HOMA-IR in the
normal weight subjects was considered as the limits of
normality (28–30).
Statistics
Statistics were calculated on SPSS 19 IBM for Windows
(SPSS Inc., Chicago, IL, USA). Microsoft Excel (Microsoft
corp., Redmond, Washington, USA) was used for calculat-
ing HOMA-IR, WBISI, TG clearance and TGR. Normal
distribution was detected by determination of skewness
and histograms. Parametric statistics were performed when
either raw or transformed data resembled normal distribu-
tion; otherwise, non-parametric tests were used. Tests for
independent or paired samples were used as appropriate. A
repeated measure analysis of variance (RM-ANOVA) was
used to analyse data from the OFTT. Corrections for devia-
tion from the assumption of sphericity were used as appro-
priate. An RM-ANOVA was performed to modulate
postprandial TG profile as predicted by weight group and
fasting TG group (all subjects were ranked according to
fasting TG and split in two equal groups with cut-off of
1.02 mmol L−1). Two-sided P-values < 0.05 were consid-
ered statistically significant. The receiver-operating charac-
teristic curves of HOMA-IR for fasting TG, total fat
percentage, abdominal fat percentage and BMI were
depicted, and the optimal cut-offs were determined by 95%
CI for the normal weight controls.
The study was approved by the Regional Committee of




The anthropometric, clinical and metabolic characteristics
for the normal weight subjects and the healthy obese
subjects are shown in Table 1. As expected, the
anthropometric data showed several differences. The
healthy obese subjects had several metabolic parameters
that were significantly increased compared with controls,
although still within the normal range (Table 1).
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Insulin sensitivity
There was a significant difference in FI and a close to
significant difference in fasting plasma glucose at baseline
(Table 1). The cut-off value of the HOMA-IR defined by
95% CI on the normal weight subjects was defined as IR
and was calculated to be >1.83. Twelve of the 18 healthy
obese subjects (66%) had IR measured by HOMA-IR.
Furthermore, insulin sensitivity was significantly lower
(higher HOMA-IR, lower WBISI) in the healthy obese sub-
jects (Table 1).
Postprandial triglyceride profiles
Results from the OFTT were analysed by RM-ANOVA,
and the estimated marginal means are shown in Fig. 1.
Serum triglyceride
Grand (all time points) mean of the total SE-TG levels was
0.54 mmol L−1 (0.20–0.94) higher in healthy obese subjects
when compared with the normal weight subjects
(P = 0.01). A significant interaction between time and
subject group was detected (P = 0.004; Greenhouse–
Geisser). The contrast showed significantly higher SE-TG
levels for the obese subjects at time points 4 (P = 0.015)
and 6 h (P = 0.009) compared with the normal weight sub-
jects (Fig. 1).
CM triglyceride
The healthy obese subjects had overall 1.8 (1.3–2.7) times
higher CM-TG (grand mean, transformed raw data,
P = 0.002) (Fig. 1). No difference in time course between
subject groups was detected.
Triglyceride clearance
The results of total SE-TG and CM-TG clearance calcula-
tions are presented in Table 2. At 6 h, a significant differ-
ence between subject groups in both SE-TG (P < 0.001)
and CM-TG (P = 0.011) clearance is noted, whereas at 8 h
the differences between subject groups can only be detected
in CM-TG clearance (P = 0.007).
TGR
The results of the serum TGR (SE-TGR) and CM-TGR are
shown in Table 2. There was a significant difference
between subject groups in both SE-TGR (P = 0.013) and
CM-TGR (P = 0.006). Significant correlations were also
found between SE-TGR and each of the variables BMI,
Table 1 Anthropometric, metabolic and clinical characteristics at
baseline between normal weight and obese subjects
Variables Baseline
Normal weight
subjects (n = 17)
Obese subjects
(n = 18)
Sex (M/F) 2/15 3/16
BMI (kg m−2) 22 (21, 23) 37 (34, 38)***
Total fat percent (%) 27 (24, 30) 49 (46, 51)***
Abdominal fat percent (%) 28 (24, 31) 56 (54, 58)***
Systolic BP (mmHg) 108 (102, 114) 124 (118, 130)***
Diastolic BP (mmHg) 65 (62, 68) 73 (69, 76)***
Glucose (mmol L−1) 4.5 (4.3, 4.7) 4.8 (4.5, 5.0)
Insulin (μmol L−1) 5.1 (4.0, 6.2) 12.1 (9.8, 14.5)***†
HOMA-IR 1 (0.8, 1.2) 2.6 (2.0, 3.2)***†
WBISI 157 (130, 191)‡ 62 (52, 74)***‡
Total cholesterol (mmol L−1) 4.5 (4.1, 4.8) 4.2 (3.9, 4.5)
LDL cholesterol (mmol L−1) 2.7 (2.3, 3.0) 2.7 (2.4, 3.1)
HDL cholesterol (mmol L−1) 1.6 (1.4, 1.8) 1.2 (1.0–1.3)***
HDL/LDL ratio 0.7 (0.5, 0.8) 0.5 (0.4, 0.6)*†
TG (mmol L−1) 0.9 (0.7, 1.0) 1.3 (1.1, 1.6)**






BMI, body mass index; BP, blood pressure; CI, confidence interval;
HDL, high-density lipoprotein; HOMA-IR, insulin resistance by the
homeostasis model assessment; LDL, low-density lipoprotein;
TG, triglyceride; WBISI, whole body insulin sensitivity index.








































Figure 1 Oral fat tolerance test in apparently healthy, obese and
normal weight subjects at study baseline. Upper part shows total
serum triglycerides (SE-TG) and lower part shows chylomicron
triglycerides (CM-TG). At 0 h, the subject ingested a standard meal.
Asterisks denote significant difference (repeated measure analysis of
variance [RM-ANOVA]: interaction time × group; post hoc comparison,
Bonferroni correction). Dagger denotes a significant difference in grand
mean (RM-ANOVA, between subjects). Double dagger denotes
significant difference in triglyceride clearance at 6 or 8 h (Wilcoxon).
Triangles represent obese subjects; circles represent normal weight
subjects. Values are estimated marginal means (95% confidence
interval).
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total bodyweight (kg), total fat mass (kg) and abdominal
fat percentage (data not shown). The cut-off value of the
grand SE-TGR and CM-TGR defined by 95% CI on the
normal weight subjects is defined abnormal (pathological),
and was calculated to be SE-TGR > 0.64. Nine (50%) of
the healthy obese subjects had an abnormal high SE-TGR
(>0.64). The cut-off value of the grand CM-TGR was cal-
culated to be CM-TGR > 0.28. Seven (39%) of the healthy
obese subjects had an abnormally high CM-TGR (>0.28).
Significant correlations were also found between CM-TGR
and each of the variables BMI, total bodyweight (kg), total
fat mass (kg) and abdominal fat percent (data not shown).
Fasting triglyceride as predictor of postprandial
triglyceride clearance
We then studied if fasting TG could reflect the postprandial
TG profile. A significant interaction between fasting TG vs.
SE-TG at various time points was detected in each group
(P = 0.008; Greenhouse–Geisser). The contrasts showed
significantly higher SE-TG levels for the obese subjects at
time points 4 (P = 0.023) and 6 h (P = 0.013) compared
with the normal weight subjects, when adjusted for fasting
TG level. The results of SE-TG clearance calculations are
presented in Table 2.
A significant interaction between time, subject group and
fasting TG category (low normal or high normal; cut-off
1.02 mmol L−1) was found (P = 0.007; Greenhouse–
Geisser). The contrast showed significantly higher post-
prandial SE-TG levels for the obese subjects with a higher
fasting SE-TG (>1.02 mmol L−1) at time points 4
(P = 0.006), 6 (P = 0.006) and 8 h (P = 0.028). The sub-
jects with high-normal fasting SE-TG had also significantly
higher SE-TG (P = 0.029) and CM-TG clearance
(P = 0.027) at 6 h, while the difference at 8 h was only
detected in CM-TG clearance (P = 0.044). Thus, the 12
obese subjects with high-normal fasting TG calculated as
TG >1.02 mmol L−1 had a significant delay in TG clearance
(Fig. 2).
Finally, there was a significant non-parametric correla-
tion between insulin sensitivity and postprandial SE-TG
clearance at 6 h (HOMA-IR; ρ = −0.636, P = 0.000,
WBISI; ρ = 0.632, P = 0.000; see Fig. 3) and CM-TG clear-
ance at 6 h (HOMA-IR; ρ = −0.493, P = 0.005, WBISI:
ρ = 0.555, P = 0.001), while at 8 h the significant correla-
tion was only found between insulin sensitivity and
CM-TG clearance (HOMA-IR; ρ = −0.527, P = 0.002,
WBISI; ρ = 0.528, P = 0.002). In addition, fasting HDL
cholesterol significantly correlated to the postprandial
CM-TGR (ρ = −0.520, P = 0.004), SE-TGR (ρ = −0.429,
P = 0.013), SE-TG clearance (ρ = 0.757, P = 0.000) and
CM-TG clearance at 6 h (ρ = 0.540, P = 0.002) and
CM-TG at 8 h (ρ = 0.608, P = 0.000).
Correlation between insulin sensitivity and
postprandial TGR
There was significant non-parametric correlations between
HOMA-IR and WBISI and both SE-TGR (HOMA-IR;
ρ = 0.395, P = 0.021, WBISI; ρ = −0.384, P = 0.025) and
CM-TGR (HOMA-IR; ρ = 0.393, P = 0.021, WBISI
ρ = −0.375, P = 0.049), respectively. Furthermore, 77% of
the obese subjects who had a pathological SE-TGR (>0.64),
and 86% who had a pathological CM-TGR (>0.28), also
had IR measured by HOMA-IR. Of the 12 subjects having
IR measured by HOMA-IR, 58% of these subjects also had
a pathological SE-TGR, and 50% of the 12 had an abnor-
mally high CM-TGR.
Table 2 Postprandial triglyceride (TG) clearance, chylomicron
triglyceride (CM-TG) clearance, triglyceride response (TGR) and
chylomicron triglyceride response (CM-TGR) after oral fat tolerance test
at baseline
Normal weight Obese P
6 h SE-TG clearance (%)* 115 (163) 61 (96) 0.000
8 h SE-TG clearance (%)* 125 (257) 103 (100) 0.123
6 h CM-TG clearance (%)* 88 (110) 60 (104) 0.011
8 h CM-TG clearance (%)* 98 (97) 78 (114) 0.007
TGR* 0.34 (1.8) 0.63 (1.5) 0.013
CM-TGR* 0.15 (0.36) 0.22 (0.5) 0.006





























Figure 2 Total serum triglycerides (SE-TG) in oral fat tolerance test in
normal weight and apparently healthy, obese subjects. Estimated
marginal means (standard error of the mean, SEM) of the observed
interaction between weight group, fasting triglyceride group and time is
plotted. Triangles represent obese subjects; circles represent normal
weight subjects. Solid lines indicate fasting triglyceride level
>1.02 mmol L−1; dashed lines indicate fasting triglyceride level
≤1.02 mmol L−1. Asterisks indicate significant contrast. Values are
estimated marginal means (95% confidence interval).
clinical obesity Metabolic changes in healthy obese M. A. Larsen et al. 353
clinical obesity 5, 349–357
© 2015 The Authors. Clinical Obesity published by John Wiley & Sons Ltd on behalf of World Obesity Federation.
Fasting triglycerides as predictor of
insulin sensitivity
Fasting TG as a predictor for IR defined as HOMA-
IR > 1.83 (see above) had the sensitivity of 83%
and the specificity of 86% with a cut-off value of
TG > 1.13 mmol L−1. BMI as a predictor of IR measured
by HOMA-IR had the sensitivity of 92% and the speci-
ficity of 81%, with a BMI cut-off >29.95. In this study,
total body fat percentage as even a better documented
predictor of IR (31) had the sensitivity of 92% and the
specificity of 72%, with a cut-off total body fat percentage
of >41%. Abdominal fat percentage as a predictor of IR
had in this study the best sensitivity of 100% and the
specificity of 82%, with a cut-off >51%. With a model
combining BMI and fasting TG (BMI × fasting TG) as pre-
dictors of IR measured by HOMA-IR, the sensitivity was
92% and the specificity was found to be 86% with a
cut-off value of >31.3.
Discussion
In this study, we have shown that young, apparently
healthy obese subjects have a postprandial delayed
metabolism of SE-TG and CM-TG when measured indi-
rectly by OFTT. When adjusted for fasting TG at baseline,
the obese subjects still had higher postprandial SE-TG
levels compared with the normal weight controls. The
obese subjects with a fasting TG > 1.02 mmol L−1 and
TG > 1.13 mmol L−1 had a significantly delayed SE-TG and
CM-TG clearance, and pathological insulin sensitivity,
respectively. Our data indicate that young, apparently
healthy obese subjects have early metabolic disturbances.
Insulin sensitivity
In agreement with other studies (28–30), 66% of the appar-
ently healthy obese subjects had IR defined by HOMA-IR
(>1.83) based on 95% CI of the normal weight subjects.
This limit is in well agreement with other studies perform-
ing comparisons of HOMA-IR to the gold standard
method glucose clamp (29). In our study with a median
BMI around 35, two-thirds had IR, and this is similar to
that observed in other reports with the same BMI (28–30).
In the postprandial state, IR is associated with increased
intestinal production of CM (32). The RM-ANOVA model
of postprandial TG clearance did not include HOMA-IR in
addition to fasting TG, in part, because of the low statis-
tical power and, in part, because the statistical model
becomes unstable when entering closely correlated vari-
ables, such as HOMA-IR and fasting TG. To explore this
further, we tested replacing fasting TG with HOMA-IR;
however, this model was inferior to the model presented
here and explained less of the variance in the data set. In
our study, as expected, the postprandial TG clearance,
SE-TGR and CM-TGR was significantly correlated to the
insulin sensitivity, reflecting the LPL activity in the endothe-
lium (33). There are some factors related to IR that we did
not measure in this study. Among them are hepatic lipid
content, gastric motility, leptin, adiponectin and modified
VLDL export. It would be of interest to investigate the
combined relationship among these factors and postpran-
dial triglyceride clearance in a future study.
Characteristics of postprandial
triglyceride metabolism
Using an OFTT test, there was a delayed peak and clear-
ance of postprandial SE-TG and CM-TG in the obese sub-
jects compared with the normal weight controls. Moreover,
CM-TG was the most sensitive test as significant differ-
ences were observed both after 6 and 8 h postprandial. A
postprandial delayed SE-TG clearance is well documented































P = 0.02; r2 = 0.17
Figure 3 Indirect total serum triglycerides (SE-TG) clearance at 6 h vs.
insulin sensitivity (whole body insulin sensitivity index, WBISI; a) and
insulin resistance (insulin resistance by the homeostasis model
assessment, HOMA-IR; b). Normal weight subjects are shown as
squares, obese subjects as circles. Linear regression line is based on
all subjects. Dashed lines indicate 95% confidence interval for
prediction.
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hypertriglyceridaemia (for review, see (33)), whereas
diverging results exist for CM-TG (15). Moreover, similar
studies in healthy, obese subjects with normal fasting TG
few reports exist, and especially for CM-TG. In two studies
of obese subjects with normal fasting TG levels, a delayed
postprandial metabolism of TG was observed, but the
study groups were small (17,18). As far as we know, no
reports exist for postprandial CM-TG. The postprandial
TG in serum and in CM has been reported to be a key
marker, and a more sensitive risk factor for atherosclerosis
than the corresponding fasting levels (34) (for review see
(35)). The greater the magnitude and duration of the post-
prandial TG response, the arterial wall will be more
exposed to postprandial TRL. The longer duration of the
postprandial TRL in the bloodstream will give more time to
replace cholesterol ester in LDL and HDL, favouring the
transformation of LDL to be a smaller and more pro-
atherogenic particle, and making HDL more dysfunctional.
Moreover, the mechanism of TRL’s influence on lowering
the HDL level is believed to be due to the enrichment of TG
to the HDL particle, which leads to increased catabolism of
Apo-A-I HDL (for review see (36)).
In our study, the fasting TG levels were significantly
higher, and the fasting HDL cholesterol was significantly
lower in the healthy obese subjects than in the normal
weight controls, although within the normal range. As
expected the fasting HDL cholesterol significantly corre-
lated to the postprandial CM-TGR, SE-TGR, SE-TG clear-
ance and CM-TG clearance at 6 h, and CM-TG at 8 h. This
implies that an OFTT can be performed to unmask early
changes in the TG metabolism in overweight and obese
subjects that may have strategic therapeutical implications.
The OFTT may be a way to identify overweight and
obese subjects at high risk of developing the metabolic
disturbances.
There are several lifestyle factors contributing to delayed
clearance of postprandial triglycerides. Among them are
low level of physical activity, low intake of omega 3 fatty
acids and high alcohol intake. Some studies have shown
that low fat and high carbohydrate diets may increase the
postprandial triglycerides. The study subjects did a 12-h
fast before the OFTT, in agreement with other studies
(20,21,37). However, if the subjects would have a longer
fasting period, one might hypothesize an even lower post-
prandial triglyceride level in both groups. However, to
explore real-life reflection of postprandial triglycerides in
the study subjects, 12 h fast is considered enough to reach
a fasting state. This was also reflected on the TG profile
during the OFTT of duration of 8 h. In addition, the study
subjects had a ‘normal’ food intake, without extensive
amount of fat and no alcohol 3 days prior to the OFTT, to
reflect the reference population. However, they did not fill
out a 3-day food or activity diary and the amount of
omega-3 fatty acids in the diet was not investigated; this
may be a weakness of the study. On the other hand, the
participants did not follow a specific diet at inclusion, as we
wanted to explore the reference population in a non-dieting
group.
Fasting triglyceride as predictor of postprandial
lipid profile
All of the apparently healthy obese subjects included in the
study had fasting TG in the normal range. In addition,
the obese subjects with high-normal fasting TG
(>1.02 mmol L−1) had delayed postprandial TG clearance
compared with both the obese subjects with low normal
fasting TG and normal weight subjects. This indicates that
in healthy, obese subjects fasting TG in the upper normal
range predicts a delayed postprandial TG clearance both in
serum and in CM. It is well known that fasting TG levels
are strongly associated to the postprandial TG metabolism
(38). Another strong influence on the postprandial TG
profile is abdominal obesity (13–16). All of the apparently
healthy, obese subjects had abdominal obesity according to
the WHO and International Diabetes Federation (waist
circumference >88 cm [80] for women and >102 cm [94]
for men). In our study, abdominal fat percentage was
strongly correlated to postprandial TG profile as expected
(13–16).
Fasting triglycerides as a predictor for
insulin sensitivity
IR is closely related to postprandial lipid metabolism
because of insulin’s influence on LPL activity in the vascu-
lar endothelium (12). In our study, 77% of the obese
subjects who had a pathological SE-TGR, and 86% who
had a pathological CM-TGR, also had IR measured by
HOMA-IR. Moreover, we also found that fasting TG, in
the normal range, predicted IR with a sensitivity of 83%
and the specificity of 86% with a cut-off value of
TG > 1.13 mmol L−1. Our findings that fasting TG in the
normal range in obese subjects can predict IR is of great
utility in clinical practice. The calibrated cut-off of fasting
TG of 1.13 mmol L−1 should therefore be followed up with
a validation study.
The advantage of this study is that it focuses on TRLs,
with a specific focus on CMs on apparently healthy, non-
dieting, obese subjects.
However, in our study there are also some areas with
limitations. First, the sex distribution is unbalanced among
our participants. This indicates a need to confirm our
results in a larger study population to explore sex differ-
ences. Second, a quantitative and direct estimate of the
triglyceride clearance like isotopic labelling is the gold
standard; in our study, triglyceride clearance was estimated
indirectly. However, OFTT has been proven to have a
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strong correlation to triglyceride clearance when compared
with other methods (19). Third, LPL activity (11) was not
measured that would also be of importance in a future
study.
Conclusion
In apparently healthy obese subjects, early metabolic dis-
turbances with delayed metabolism of postprandial SE-TG
and CM can be observed. When adjusted for fasting TG at
baseline, the obese subjects still had higher postprandial
SE-TG levels compared with normal weight controls. A
sub-analysis revealed that fasting TG level in the higher
normal range predicted delayed postprandial TG clearance
and IR, but only in obese subjects. Further studies should
focus on a new and possibly lower normal range for
fasting TG in obese subjects, as this may have therapeutic
implications.
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